Eris Lifesciences approves preferential allotment of 23,06,372 equity shares at INR 1,835.35 per share as consideration for acquiring 16,74,493 Swiss Parenterals shares, making Swiss Parenterals a wholly owned subsidiary; post-issue paid-up capital rises to INR 13.85 crore.